This approach not only responds to emerging evidence, indicating that understanding cancer progression requires delineating how extrinsic factors cooperate with oncogenic mutations [65–67], but also holds potential for reaching a consensus on the specific contentious issue of the p53 GOF effects. This evidence concerns the gene TP53 and cancer.